Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
9.15M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
1.88M
-
Shares change
-
-168K
-
Total reported value, excl. options
-
$3.19M
-
Value change
-
-$295K
-
Number of buys
-
10
-
Number of sells
-
-7
-
Price
-
$1.70
Significant Holders of AYTU BIOPHARMA, INC - Common Stock (AYTU) as of Q4 2024
30 filings reported holding AYTU - AYTU BIOPHARMA, INC - Common Stock as of Q4 2024.
AYTU BIOPHARMA, INC - Common Stock (AYTU) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.88M shares
of 9.15M outstanding shares and own 20.55% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (1.09M shares), Stonepine Capital Management, LLC (408K shares), ARMISTICE CAPITAL, LLC (150K shares), RENAISSANCE TECHNOLOGIES LLC (75.4K shares), GEODE CAPITAL MANAGEMENT, LLC (42.7K shares), VANGUARD GROUP INC (27.9K shares), BlackRock, Inc. (22.8K shares), ACADIAN ASSET MANAGEMENT LLC (14.6K shares), TWO SIGMA SECURITIES, LLC (11.7K shares), and CITADEL ADVISORS LLC (11.1K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.